Mouse prostate cancer cells (RM-1)

Prostate cancer research frequently employs RM-1 cells for studies related to tumor formation processes, cancer spread mechanisms and resistance to therapy. Syngeneic mice tumor formation capability in RM-1 cells provides an excellent platform for testing new anticancer treatments such as chemotherapy, radiation therapy, and immunotherapy. Scientists study RM-1 cells to understand how oncogenic pathways like Ras and Myc contribute to prostate cancer development. Researchers use these cells to study tumor microenvironment dynamics as well as angiogenesis and immune cell interactions. RM-1 cells serve as an appropriate platform for genetic engineering experiments which allow scientists to analyze gene functions and create precise therapeutic strategies. RM-1 cells provide essential support for both prostate cancer research progression and patient treatment advancements.